Doctor profile · Federal record
Dr. Wechita Recalde, NP-C, FNP-BC
Nurse Practitioner · Tucson, AZ
- NPI 1366017584
- Accepts Medicare
- MIPS 99.2 / 100 · 2023
- 5 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
2732 N Alvernon Way
Tucson, AZ 857121804
(520) 329-4224 - Mailing address
-
8864 E Abrams Loop
Tucson, AZ 857102000
Credentials & registration
- NPI registered
- May 2021 — 5 yrs on file
- Profile last updated
- October 12, 2021
- Year of graduation
- 2021 — 5 yrs since
- Specialty taxonomy
- 363L00000X — NUCC code
- State license (1)
- Arizona #257981
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1366017584. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
6,286
Distinct HCPCS
10
Medicare allowed
$78,778
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J7345 |
Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | 5,000 | 20 | $2 | |
17003 |
Destruction of precancer skin growth, 2-14 growths | 393 | 85 | $6 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 218 | 139 | $73 | |
17000 |
Destruction of precancer skin growth, 1 growth | 138 | 117 | $40 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 121 | 121 | $92 | |
11102 |
Biopsy of related skin growth, first growth | 108 | 98 | $74 | |
17110 |
Destruction of skin growth, 1-14 growths | 97 | 81 | $94 | |
11103 |
Biopsy of related skin growth, each additional growth | 73 | 42 | $42 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 30 | 27 | $140 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 28 | 18 | $105 |
In context: peer comparison
Among 37 peers in Tucson Nurse Practitioner, average services per provider: 127. This provider delivers 49× the peer median.Open Payments
Industry payments received
All-time total
$1,333
Transactions
76
Manufacturers
14
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 23 | $450.73 | |
| Janssen Biotech, INC. | 26 | $355.09 | |
| Genzyme Corporation | 10 | $212.07 | |
| Pfizer INC. | 3 | $45.85 | |
| Novartis Pharmaceuticals Corporation | 2 | $41.42 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $40.40 | |
| Amgen INC. | 2 | $35.82 | |
| Regeneron Healthcare Solutions, INC. | 2 | $32.86 | |
| Leo Pharma INC. | 1 | $23.00 | |
| Incyte Corporation | 1 | $22.18 | |
| Dermavant Sciences, INC. | 1 | $19.33 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | 1 | $18.15 | |
| Kyowa Kirin, INC. | 1 | $18.13 | |
| Sun Pharmaceutical Industries INC. | 1 | $17.51 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
759
Patients
492
Total drug cost
$107,077
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Clobetasol Propionate | Generic | 97 | 64 | $5,301 |
| Ketoconazole | Generic | 89 | 63 | $2,426 |
| Hydrocortisone | Generic | 76 | 62 | $778 |
| Triamcinolone Acetonide | Generic | 74 | 65 | $580 |
| Mupirocin | Generic | 67 | 59 | $671 |
| Prednisone | Generic | 63 | 46 | $370 |
| Doxycycline Hyclate | Generic | 52 | 38 | $1,349 |
| Hydroxyzine Hcl | Generic | 51 | 28 | $466 |
| Ciclopirox | Generic | 48 | 20 | $2,519 |
| Metronidazole | Generic | 31 | 17 | $1,994 |
Frequently asked questions
What is Dr. Wechita Recalde's medical specialty?
Dr. Wechita Recalde practices Nurse Practitioner in Tucson, AZ.
Where does Dr. Wechita Recalde practice?
Dr. Wechita Recalde practices at 2732 N Alvernon Way, Tucson, AZ 857121804. Office phone: 5203294224.
What is Dr. Wechita Recalde's NPI?
Dr. Wechita Recalde's National Provider Identifier (NPI) is 1366017584, issued by NPPES.
Does Dr. Wechita Recalde accept Medicare assignment?
Yes. Dr. Wechita Recalde accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Wechita Recalde commonly perform?
Top Medicare-reported procedures in 2023: Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg (HCPCS J7345); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.